V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300005233 | 300003547 | 1.84 | 86.4 | Adjuvant (A) | null | 2017-10-28 | CARBOPLATIN + RT | N | N | 300004450 | ESPAC TRIAL |
| 300005234 | 300003547 | 1.58 | 143.3 | Neo-adjuvant (N) | 2016-02-07 | 2016-02-17 | Oxaliplatin + Modified de Gramont | 02 | N | 300004450 | PEMBROLIZUMAB |
| 300005235 | 300003548 | 1.74 | 111 | Adjuvant (A) | 2019-01-12 | 2019-01-13 | Capecitabine (21days) + Carboplatin | N | Y | 300006025 | CARBOPLATIN + RT |
| 300005236 | 300003548 | 1.65 | 58.8 | Adjuvant (A) | 2018-01-23 | 2018-02-05 | Oxaliplatin + Modified de Gramont | N | N | 300006025 | GEMCARBO |
| 300005237 | 300003548 | 1.71 | 115 | Neo-adjuvant (N) | 2017-08-01 | 2017-08-05 | Capecitabine (14 days)+Carboplatin | N | N | 300006025 | CARBOPLATIN |
| 300005238 | 300003549 | 1.89 | 83.7 | Palliative (P) | 2018-09-02 | 2018-09-03 | ESPAC-4 TRIAL | 02 | N | 300008283 | GEMCITABINE + NAB-PACLITAXEL |
| 300005239 | 300003549 | null | 52.8 | null | 2019-03-08 | 2019-03-08 | Carboplatin + Etoposide iv&po | 02 | null | 300008283 | CARBO + FLUOROURACIL |
| 300005240 | 300003550 | 1.61 | 3.7 | Palliative (P) | 2018-08-13 | 2018-08-17 | CARBOPLATIN + Cetuximab + FLUOROURACIL | 02 | N | 300009358 | PEMBROLIZUMAB |
| 300005241 | 300003550 | 0 | 69.8 | Palliative (P) | 2017-01-19 | 2017-02-19 | Carboplatin + Etoposide iv&po | 01 | null | 300009358 | CARBOPLATIN |
| 300005242 | 300003551 | 1.79 | 108 | Palliative (P) | 2017-05-13 | 2017-06-03 | Cetuximab + CISPLATIN + FLUOROURACIL | N | N | 300012207 | CARBO + FLUOROURACIL |
| 300005243 | 300003551 | 1.64 | 45.2 | Palliative (P) | 2019-12-15 | 2019-12-20 | Capecitabine + Oxaliplatin 21day | 02 | null | 300012207 | IPILIMUMAB + NIVOLUMAB |
| 300005244 | 300003552 | 1.53 | 96 | null | null | 2015-09-06 | Folfirinox | null | null | 300016451 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300005245 | 300003552 | 1.72 | 81.5 | Palliative (P) | 2016-02-12 | 2016-02-13 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | N | N | 300016451 | GEMCITABINE + NAB-PACLITAXEL |
| 300005246 | 300003552 | null | 66 | Neo-adjuvant (N) | 2017-07-21 | 2017-08-17 | Carboplatin + Etoposide IV 5 day | N | N | 300016451 | PACLITAXEL |
| 300005247 | 300003553 | null | 80.9 | Palliative (P) | 2017-06-17 | 2017-06-21 | CISPLATIN + VINORELBINE | 2 | N | 300018371 | ESPAC TRIAL |
| 300005248 | 300003554 | 1.43 | 51 | Palliative (P) | 2017-01-30 | 2017-01-30 | Rituximab | 02 | N | 300019166 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 300005249 | 300003555 | 1.52 | 45.2 | Adjuvant (A) | 2015-09-11 | 2015-10-02 | FLUOROURACIL + MITOMYCIN + RT | 2 | N | 300020983 | VEMURAFENIB |
| 300005250 | 300003555 | 1.48 | 75.3 | Adjuvant (A) | 2018-04-27 | 2018-05-07 | ESPAC-4 TRIAL | N | N | 300020983 | CAPECITABINE + GEMCITABINE |
| 300005251 | 300003556 | 1.58 | 60.2 | Neo-adjuvant (N) | 2019-06-16 | 2019-07-13 | FEC 100 + DOCETAXEL | 02 | N | 300023285 | CISPLATIN + FLUOROURACIL + RT |
| 300005252 | 300003556 | 1.79 | 79.5 | Curative (C) | 2018-12-22 | 2018-12-26 | Carboplatin + Etoposide iv&po | 01 | N | 300023285 | OXALIPLATIN + MDG |
| 300005253 | 300003556 | 1.72 | 75 | Curative (C) | 2016-08-09 | 2016-08-14 | Cisplatin + Fluorouracil + RT 5day | 02 | N | 300023285 | CAPECITABINE + GEMCITABINE |
| 300005254 | 300003557 | 1.75 | 113 | Curative (C) | 2019-03-11 | 2019-03-24 | ESPAC-4 TRIAL | 02 | Y | 300004717 | GEMCARBO |
| 300005255 | 300006341 | null | 75.4 | Not known (9) | null | 2017-01-16 | GEMCITABINE | N | N | 300000021 | GEMCITABINE |
| 300005256 | 300003558 | 1.69 | 45.3 | Curative (C) | 2014-08-07 | 2014-09-29 | CISPLATIN + RT | N | N | 300000026 | CISPLATIN + RT |
| 300005257 | 300003558 | 1.58 | null | Neo-adjuvant (N) | 2013-08-05 | 2013-09-27 | Cisplatin + Radiotherapy | N | null | 300000026 | CISPLATIN + RT |
| 300005258 | 300003558 | 1.61 | 80 | Palliative (P) | 2017-06-08 | 2017-06-14 | CISPLATIN + GEMCITABINE | 2 | N | 300000026 | CISPLATIN + GEMCITABINE |
| 300005259 | 300003559 | null | 84 | Palliative (P) | 2013-05-04 | 2013-05-21 | Cisplatin + Gemcitabine (D 1 & 8) | N | null | 300000056 | CISPLATIN + GEMCITABINE |
| 300005260 | 300003561 | 0 | 78 | Palliative (P) | 2017-04-14 | 2017-05-29 | CISPLATIN + GEMCITABINE | 02 | N | 300000085 | CISPLATIN + GEMCITABINE |
| 300005261 | 300003562 | 1.8 | 118 | Palliative (P) | 2018-02-25 | 2018-03-27 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | Y | 300000115 | CISPLATIN + GEMCITABINE |
| 300005262 | 300003562 | 1.48 | 80 | Adjuvant (A) | null | 2013-05-27 | Gemcitabine 1000mg/m2 D1 8 15 | 2 | N | 300000115 | GEMCITABINE |
| 300005263 | 300003563 | 1.57 | 56 | Curative (C) | 2015-12-26 | 2016-01-20 | Cisplatin 100 + RT(H&N) 1 day | N | null | 300000147 | CISPLATIN + RT |
| 300005264 | 300003563 | 1.65 | 54.7 | Palliative (P) | null | 2016-05-04 | Cisplatin + Gemcitabine (D 1 & 8) | N | null | 300000147 | CISPLATIN + GEMCITABINE |
| 300005265 | 300003564 | 1.68 | 69 | Palliative (P) | 2014-04-22 | 2014-05-03 | Gemcitabine weekly | N | Y | 300000176 | GEMCITABINE |
| 300005268 | 300003566 | 1.77 | null | null | 2014-03-05 | 2014-03-11 | Cisplatin + Gemcitabine (D 1 & 8) | N | null | 300000380 | CISPLATIN + GEMCITABINE |
| 300005269 | 300003568 | 1.72 | 84.7 | Palliative (P) | 2016-09-29 | 2016-10-23 | CISPLATIN + RT | N | null | 300000380 | CISPLATIN + RT |
| 300005270 | 300007556 | 1.67 | 85 | Palliative (P) | null | 2013-07-24 | Cisplatin + Gemcitabine (D 1 & 8) | null | null | 300000626 | CISPLATIN + GEMCITABINE |
| 300005271 | 300007556 | 1.61 | 63.4 | Curative (C) | 2015-01-21 | 2015-02-10 | Cisplatin + Radiotherapy | 02 | null | 300000626 | CISPLATIN + RT |
| 300005272 | 300003569 | 1.84 | 83 | Adjuvant (A) | 2013-04-30 | 2013-05-24 | Gemcitabine weekly | 02 | N | 300000670 | GEMCITABINE |
| 300005273 | 300003570 | 1.61 | 55 | null | 2013-12-23 | 2014-01-02 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | N | 300000722 | CISPLATIN + GEMCITABINE |
| 300005275 | 300003571 | 1.69 | 62.5 | Palliative (P) | 2017-06-11 | 2017-06-11 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | null | 300000741 | GEMCITABINE |
| 300005276 | 300003571 | 1.76 | 86.4 | null | 2015-09-11 | 2016-09-06 | CISPLATIN + GEMCITABINE | N | N | 300000741 | CISPLATIN + GEMCITABINE |
| 300005277 | 300003572 | 1.73 | null | Palliative (P) | 2015-09-13 | 2015-10-04 | Cisplatin + Gemcitabine (D 1 & 8) | null | null | 300000802 | CISPLATIN + GEMCITABINE |
| 300005278 | 300003573 | null | null | Curative (C) | 2017-05-17 | 2017-05-17 | Cisplatin + Radiotherapy | null | null | 300000822 | CISPLATIN + RT |
| 300005279 | 300003573 | 1.66 | null | Curative (C) | 2013-04-19 | 2013-04-23 | CISPLATIN + RT | N | Y | 300000822 | CISPLATIN + RT |
| 300005280 | 300003574 | 1.78 | null | Adjuvant (A) | 2013-06-02 | 2013-06-23 | CISPLATIN + RT | N | null | 300000845 | CISPLATIN + RT |
| 300005281 | 300003574 | 1.73 | 73.7 | Palliative (P) | null | 2014-04-28 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 300000845 | CISPLATIN + GEMCITABINE |
| 300005282 | 300003576 | 1.66 | 80 | Adjuvant (A) | 2016-12-09 | 2016-12-09 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | N | 300000879 | GEMCITABINE |
| 300005283 | 300003578 | 1.6 | 83.5 | Adjuvant (A) | 2016-08-26 | 2016-08-27 | GEMCITABINE | N | N | 300000888 | GEMCITABINE |
| 300005284 | 300003579 | 1.57 | 60 | Palliative (P) | 2017-10-09 | 2017-11-20 | GEMCITABINE | 2 | N | 300000958 | GEMCITABINE |
| 300005285 | 300003580 | null | null | Adjuvant (A) | 2017-10-05 | 2017-10-13 | Cisplatin + Radiotherapy | null | null | 300000988 | CISPLATIN + RT |